(VIANEWS) – Xylem (XYL), Middlesex Water Company (MSEX), Brookfield (BAM) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Xylem (XYL)
22.6% sales growth and 9.61% return on equity
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands. The Applied Water segment provides pumps, valves, heat exchangers, controls, and dispensing equipment systems under the Goulds Water Technology, Bell & Gossett, A-C Fire Pump, Standard Xchange, Lowara, Jabsco, Xylem Vue, and Flojet brands. The Measurement & Control Solutions segment offers smart meters, networked communication devices, data analytics, test equipment, controls, sensor devices, software and managed services, and critical infrastructure services; and software and services, including cloud-based analytics, remote monitoring and data management, leak detection, condition assessment, asset management, and pressure monitoring solutions, as well as testing equipment. This segment sells its products under the Pure Technologies, Sensus, Smith Blair, WTW, Xylem Vue, and YSI brands. The Integrated Solutions and Services segment provides maintenance services, mobile services, digital outsourced solutions, wastewater systems, environmental remediation, odor and corrosion control, filtration, reverse osmosis, ion exchange, and deionization under Aquapro, WaterOne, and Ion Pure brands. Xylem Inc. was formerly known as ITT WCO, Inc. and changed its name to Xylem Inc. in May 2011. Xylem Inc. was incorporated in 2011 and is headquartered in Washington, District of Columbia.
Earnings Per Share
As for profitability, Xylem has a trailing twelve months EPS of $2.79.
PE Ratio
Xylem has a trailing twelve months price to earnings ratio of 45.92. Meaning, the purchaser of the share is investing $45.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.61%.
Volume
Today’s last reported volume for Xylem is 885681 which is 23.59% below its average volume of 1159210.
Yearly Top and Bottom Value
Xylem’s stock is valued at $128.11 at 01:22 EST, under its 52-week high of $138.46 and way higher than its 52-week low of $87.59.
Revenue Growth
Year-on-year quarterly revenue growth grew by 40.4%, now sitting on 7.95B for the twelve trailing months.
2. Middlesex Water Company (MSEX)
14.5% sales growth and 7.62% return on equity
Middlesex Water Company owns and operates regulated water utility and wastewater systems. It operates in two segments, Regulated and Non-Regulated. The Regulated segment collects, treats, and distributes water on a retail and wholesale basis to residential, commercial, industrial, and fire protection customers in parts of New Jersey, Delaware, and Pennsylvania. This segment also includes regulated wastewater systems in New Jersey and Delaware. The Non-Regulated segment provides non-regulated contract services for the operation and maintenance of municipal and private water and wastewater systems in New Jersey and Delaware. The company was incorporated in 1896 and is headquartered in Iselin, New Jersey.
Earnings Per Share
As for profitability, Middlesex Water Company has a trailing twelve months EPS of $1.76.
PE Ratio
Middlesex Water Company has a trailing twelve months price to earnings ratio of 28.66. Meaning, the purchaser of the share is investing $28.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.62%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.6%, now sitting on 166.27M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 39.4% and 12.7%, respectively.
Moving Average
Middlesex Water Company’s value is under its 50-day moving average of $50.51 and way under its 200-day moving average of $63.96.
Volume
Today’s last reported volume for Middlesex Water Company is 85534 which is 51.84% below its average volume of 177632.
3. Brookfield (BAM)
10% sales growth and 18.68% return on equity
Brookfield Asset Management Ltd. is a real estate investment firm specializing in alternative asset management services. Its renewable power and transition business includes the operates in the hydroelectric, wind, solar, distributed generation, and sustainable solution sector. The company's infrastructure business engages in the utilities, transport, midstream, and data infrastructure sectors. In addition, its private equity business offers industrial, infrastructure, and business services sectors; and real estate business, which includes housing, logistics, hospitality, science and innovation, office, and retail sectors. Further, it provides credit business; and insurance solution in the reinsurance, annuities, operating platform, and investment solutions sectors. Brookfield Asset Management Ltd. was incorporated in 2022 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, Brookfield has a trailing twelve months EPS of $1.13.
PE Ratio
Brookfield has a trailing twelve months price to earnings ratio of 34.85. Meaning, the purchaser of the share is investing $34.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.68%.
4. Criteo (CRTO)
9.3% sales growth and 7.09% return on equity
Criteo S.A., a technology company, provides marketing and monetization services on the open Internet in North and South America, Europe, the Middle East, Africa, and the Asia-Pacific. The company's Criteo Shopper Graph, which derives clients' proprietary commerce data, such as transaction activity on their digital properties. It also offers Criteo AI Engine solutions, including lookalike finder, recommendation, and predictive bidding algorithms; recommendation algorithms, dynamic creative optimization+, sponsored product placement algorithms, and other product placement algorithms. The company's technology comprises data synchronization, storage, and analysis of distributed computing infrastructure in various geographies, as well as fast data collection and retrieval using multi-layered caching infrastructure; and experimentation platform, an offline/online testing platform to enhance the capabilities and effectiveness of prediction models. In addition, it provides Criteo Marketing Solutions that allow commerce companies to address various marketing goals by engaging their consumers with personalized ads across the web, mobile, and offline store environments; and Criteo Retail Media solutions, which allows retailers to generate advertising revenues from consumer brands, and/or to drive sales for themselves, by monetizing their data and audiences through personalized ads, either on their own digital property or on the open Internet. Further, the company offers real-time advertising technology and trading infrastructure, delivering advanced media buying, selling, and packaging capabilities for media owners, agencies, performance advertisers, and third-party AdTech platforms. It serves companies in digital retail, travel, and classifieds sectors. Criteo S.A. was incorporated in 2005 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, Criteo has a trailing twelve months EPS of $0.88.
PE Ratio
Criteo has a trailing twelve months price to earnings ratio of 39.16. Meaning, the purchaser of the share is investing $39.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.09%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 55.1% and 11.3%, respectively.
Moving Average
Criteo’s worth is below its 50-day moving average of $35.20 and way higher than its 200-day moving average of $29.49.
5. Goldman Sachs Group (GS)
7.7% sales growth and 7.97% return on equity
The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Goldman Sachs Group has a trailing twelve months EPS of $22.86.
PE Ratio
Goldman Sachs Group has a trailing twelve months price to earnings ratio of 17.04. Meaning, the purchaser of the share is investing $17.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.97%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.1%, now sitting on 46.73B for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 30, 2024, the estimated forward annual dividend rate is 11 and the estimated forward annual dividend yield is 2.51%.
Sales Growth
Goldman Sachs Group’s sales growth is 16.1% for the present quarter and 7.7% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 185.4% and 61.8%, respectively.
Previous days news about Goldman Sachs Group(GS)
- According to FXStreet on Tuesday, 14 May, "On the high side, Goldman Sachs Group Inc. (GS) gained around 1.6%, climbing seven points to trade above $460.00 per share. "
6. Kamada Ltd. (KMDA)
5.1% sales growth and 3.94% return on equity
Kamada Ltd., together with its subsidiaries, provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD. It also provides KamRho (D) IM for prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN for Allergic rhinitis and Urticaria; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for cytomegalovirus virus; RUCONEST for angioedema attacks; heparin sodium injection for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. Further, it offers IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; and ELIGARD for prostate cancer. The company markets its products through strategic partners in the United States, as well as through distributors internationally. It has strategic partnerships with Takeda Pharmaceuticals Company Limited; PARI GmbH; and Kedrion Biopharma. Kamada Ltd. was incorporated in 1990 and is headquartered in Rehovot, Israel.
Earnings Per Share
As for profitability, Kamada Ltd. has a trailing twelve months EPS of $0.15.
PE Ratio
Kamada Ltd. has a trailing twelve months price to earnings ratio of 34.33. Meaning, the purchaser of the share is investing $34.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.94%.
Moving Average
Kamada Ltd.’s value is below its 50-day moving average of $5.68 and below its 200-day moving average of $5.39.
Sales Growth
Kamada Ltd.’s sales growth is 23.8% for the ongoing quarter and 5.1% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 250% and 50%, respectively.
